Neurology
Intracranial Pressure
0
Pipeline Programs↗
1
Active Trials↗
0
Companies Involved↗
Intracranial Pressure is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
10
clinical trials
Completed5 · 50%
Unknown status2 · 20%
Withdrawn2 · 20%
Not yet recruiting1 · 10%
Clinical Trials
Trial Activity
10 trials
Point of Care Optic Nerve Sheath Ultrasound to Assess Intracranial Pressure
Completed·—·Phase 1·NCT04686344·50 enrolled
Adding Dexmedetomidine to Mannitol to Attenuate the Increase of Intracranial Pressure
Completed·—·Phase 2/3·NCT07064720·60 enrolled
The Effect of Clevidipine on Intracranial Pressure and Cerebral Perfusion Pressure (CCP) in Brain Injured Patients
Withdrawn·—·Phase 4·NCT01526876
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)